Vascular adhesion protein-1-targeted PET imaging in autoimmune myocarditis

Background. Vascular adhesion protein-1 (VAP-1) is an adhesion molecule and primary amine oxidase, and Gallium-68-labeled 1,4,7,10-tetraazacyclododecane-N,N',N,N'-tetra-acetic acid conjugated sialic acid-binding immunoglobulin-like lectin 9 motif containing peptide ([Ga-68]Ga-DOTA-Siglec-9) is a positron emission tomography (PET) tracer targeting VAP-1. We evaluated the feasibility of PET imaging with [Ga-68]Ga-DOTA-Siglec-9 for the detection of myocardial lesions in rats with autoimmune myocarditis.Methods. Rats (n = 9) were immunized twice with porcine cardiac myosin in complete Freund's adjuvant. Control rats (n = 6) were injected with Freund's adjuvant alone. On day 21, in vivo PET/computed tomography (CT) imaging with [Ga-68]Ga-DOTA-Siglec-9 was performed, followed by ex vivo autoradiography, histology, and immunohistochemistry of tissue sections. In addition, myocardial samples from three patients with cardiac sarcoidosis were studied.Results. [Ga-68]Ga-DOTA-Siglec-9 PET/CT images of immunized rats showed higher uptake in myocardial lesions than in myocardium outside lesions (SUVmean, 0.5 +/- 0.1 vs 0.3 +/- 0.1; P = .003) or control rats (SUVmean, 0.2 +/- 0.03; P < .0001), which was confirmed by ex vivo autoradiography of tissue sections. Immunohistochemistry showed VAP-1-positive staining in lesions of rats with myocarditis and in patients with cardiac sarcoidosis.Conclusion. VAP-1-targeted [Ga-68]Ga-DOTA-Siglec-9 PET is a potential novel technique for the detection of myocardial lesions.

Automated summary

This study successfully demonstrated the feasibility of using [Ga-68]Ga-DOTA-Siglec-9 PET imaging to detect myocardial lesions in rats with autoimmune myocarditis, suggesting its potential as a novel technique.